Answer
Yes, the Sandoz Limited cefalexin 250 mg/5 ml oral suspension product is contraindicated in patients with porphyria.
Sources for this answer
- Cefalexin oral suspension BP 250mg/5mlSandoz Limited · emc · SmPC §4.3 Contraindications · Version 7Document updated
Sources checked